Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Expert Rev Clin Immunol. 2011 Jan;7(1):75-91. doi: 10.1586/eci.10.81.
Photodynamic therapy (PDT) is a rapidly developing cancer treatment that utilizes the combination of nontoxic dyes and harmless visible light to destroy tumors by generating reactive oxygen species. PDT produces tumor-cell destruction in the context of acute inflammation that acts as a 'danger signal' to the innate immune system. Activation of the innate immune system increases the priming of tumor-specific T lymphocytes that have the ability to recognize and destroy distant tumor cells and, in addition, lead to the development of an immune memory that can combat recurrence of the cancer at a later point in time. PDT may be also successfully combined with immunomodulating strategies that are capable of overcoming or bypassing the escape mechanisms employed by the progressing tumor to evade immune attack. This article will cover the role of the immune response in PDT anti-tumor effectiveness. It will highlight the milestones in the development of PDT-mediated anti-tumor immunity and emphasize the combination strategies that may improve this therapy.
光动力疗法(PDT)是一种迅速发展的癌症治疗方法,它利用无毒染料和无害可见光的结合,通过产生活性氧来破坏肿瘤。PDT 在急性炎症的情况下产生肿瘤细胞破坏,作为“危险信号”作用于先天免疫系统。先天免疫系统的激活增加了肿瘤特异性 T 淋巴细胞的启动,这些淋巴细胞有能力识别和破坏远处的肿瘤细胞,此外,还导致免疫记忆的发展,从而在以后的时间里对抗癌症的复发。PDT 还可以与免疫调节策略成功结合,这些策略能够克服或绕过进展中的肿瘤逃避免疫攻击所采用的逃逸机制。本文将涵盖免疫反应在 PDT 抗肿瘤有效性中的作用。它将强调 PDT 介导的抗肿瘤免疫发展的里程碑,并强调可能改善这种治疗的联合策略。